Real-time data: How to gain the edge amid clinical services consolidation

Real-time data: How to gain the edge amid clinical services consolidation

Against a backdrop of rapid innovation, the pharmaceutical services industry is undergoing a wave of consolidation that is fundamentally reshaping competitive dynamics and creating threats and opportunities for clinical technology providers and contract research organizations (CROs). A recent example is Thermo Fisher Scientific’s acquisition of Clario Holdings, an electronic endpoint data and clinical outcome assessment…

Read More
Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics, Inc.

Valuation Based on our probability-adjusted DCF model that takes into account potential future revenues from tecarfarin in LVAD, ESKD+AFib, and mechanical heart valves, CVKD is valued at $30.00/share. This model is highly dependent on the continued clinical success of tecarfarin and will be adjusted accordingly based on future clinical results. Stand out Based on our…

Read More